antiaging

Global Venture capital for 2018 and 2019 has been about $200-250 billion. US Venture capital reached $130 billion. This surpassed the level in 2000 when it was $100 billion. There is $9-10 billion per year funding Artificial Intelligence and $5.8 …

There are a few dozen antiaging rejuvenation treatments that are progressing through pre-clinical and clinical trials. Lifespan.io is tracking the antiaging rejuvenation treatments on a rejuvenation roadmap. Two treatments are in phase 3 clinical trial. Samumed is developing drugs for …

Underdog Pharma is developing disease-modifying treatments for atherosclerosis and other age-related diseases. They want to prevent or reverse atherosclerosis by removing a harmful lipid known as 7-ketocholesterol (7KC) from the arterial walls. Underdog has a molecule that can extract the …

Scientists at the MDI Biological Laboratory, in collaboration with scientists from the Buck Institute for Research on Aging in Novato, Calif., and Nanjing University in China, have identified synergistic cellular pathways for longevity that amplify lifespan fivefold in C. elegans, …

George Church describes the leading edge of biotechnology. He described antiaging and gene reading and writing capabilities. George Church Described Other Leading Edge Biotechnology They are closer to making organoids in days and they are vascularized. Having veins will enable …

In mouse models of Alzheimer’s disease, the drug candidates (CMS121 and J147) improve memory and slow the degeneration of brain cells. Researchers have shown how these compounds can also slow aging in healthy older mice, blocking the damage to brain …

Telomerase is present in 90% of human cancer cells and contributes significantly to proliferative abilities and immortality of cancer cells. MAIA Biotechnology is developing a Telomerase-Mediated Approach to Fighting Cancer. Telomerase is either absent or shows low activity in normal …